2018: THE YEAR IN REVIEW

摘要

An analysis of the news stories on Cleanroomtechnology.com reveals that high-value budgets for expansion projects have been put into motion in 2018. For many in the drug-making business, last year's priority has been to boost manufacturing capacity. Chiefly, these investments have been made to cater for increasing demand concerning highly potent active pharmaceutical ingredients (HPAPIs). The reason is simple: a significant proportion of new drugs under development require HPAPIs.